ReP USP - Resultado da busca

Filtros : "FCF" "2011" "Annual Meeting and Exposition of the American Society of Hematology (ASH)" Limpar

Filtros

Trabalho de evento-resumo periodico
Polymorphisms in antitrombin (SERPINC1) and tissue factor pathway inhibitor (TFPI) genes are associated with recurrent pregnancy loss (2011)
Guerra-Shinohara, Elvira Maria ; Bertinato, Juliano Felix; Giusti, Kelma Cordeiro da Silva; Seino, Fernanda Midori; Bueno, Carolina Tosin; Carvalho, Mario Henrique Burlacchini de; Amorim Filho, Antônio Gomes; Zugaib, Marcelo; Chiattone, Carlos Sérgio
Source: Blood. Conference titles: Annual Meeting and Exposition of the American Society of Hematology (ASH). Unidades: FCF, FM
Assunto: POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA-SHINOHARA, Elvira Maria et al. Polymorphisms in antitrombin (SERPINC1) and tissue factor pathway inhibitor (TFPI) genes are associated with recurrent pregnancy loss. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 28 abr. 2024. , 2011
APA
Guerra-Shinohara, E. M., Bertinato, J. F., Giusti, K. C. da S., Seino, F. M., Bueno, C. T., Carvalho, M. H. B. de, et al. (2011). Polymorphisms in antitrombin (SERPINC1) and tissue factor pathway inhibitor (TFPI) genes are associated with recurrent pregnancy loss. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Guerra-Shinohara EM, Bertinato JF, Giusti KC da S, Seino FM, Bueno CT, Carvalho MHB de, Amorim Filho AG, Zugaib M, Chiattone CS. Polymorphisms in antitrombin (SERPINC1) and tissue factor pathway inhibitor (TFPI) genes are associated with recurrent pregnancy loss. Blood. 2011 ; 118( 21): 323-324 res. 331.[citado 2024 abr. 28 ]
Vancouver
Guerra-Shinohara EM, Bertinato JF, Giusti KC da S, Seino FM, Bueno CT, Carvalho MHB de, Amorim Filho AG, Zugaib M, Chiattone CS. Polymorphisms in antitrombin (SERPINC1) and tissue factor pathway inhibitor (TFPI) genes are associated with recurrent pregnancy loss. Blood. 2011 ; 118( 21): 323-324 res. 331.[citado 2024 abr. 28 ]
Trabalho de evento-resumo periodico
ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia (2011)
Vivona, Douglas; Lima, Luciene Terezina; Bueno, Carolina Tosin; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria; Chiattone, Carlos Sérgio; Guerra-Shinohara, Elvira Maria
Source: Blood. Conference titles: Annual Meeting and Exposition of the American Society of Hematology (ASH). Unidade: FCF
Subjects: LEUCEMIA MIELOIDE, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 28 abr. 2024. , 2011
APA
Vivona, D., Lima, L. T., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2011). ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Vivona D, Lima LT, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli M, Chiattone CS, Guerra-Shinohara EM. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. 2011 ; 118( 21): 618 res. 604.[citado 2024 abr. 28 ]
Vancouver
Vivona D, Lima LT, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli M, Chiattone CS, Guerra-Shinohara EM. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. 2011 ; 118( 21): 618 res. 604.[citado 2024 abr. 28 ]

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024